Recon: Merck wagers $250M in circular RNA deal with Orna Therapeutics; US to send up to 442,000 Jynneos doses to states
ReconMichael Mezher
Biologics/ biosimilars/ vaccinesBiotechnologyDiagnostics/IVDsEuropeGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/Policy